Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01247454 · ClinicalTrials.gov registry record · NA
Medication Management and Culture of Safety
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 7,000
- Enrollment target
NCT01247454 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 7,000 participants.
The verdict
NCT01247454, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 7,000 participants
- Enrollment target
Study Summary
There will be no significant decrease in the use of low dose acetylsalicylic acid (ASA) therapy for primary prevention across the three intervention arms from baseline to completion of the project. There will be no significant differences in the percentage of patients with diabetes mellitus greater than 44 years of age on low dose ASA therapy for primary prevention across the three arms of the study using repeated measures from baseline to completion of the project.
Interventions
- BEHAVIORAL academic detailing
- BEHAVIORAL Electronic Health Record (EHR) prompt
- BEHAVIORAL EHR prompt and patient prompt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,000 participants |
| Start Date | 2009-07 |
| Est. Completion | 2010-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01247454
The ClinicalTrials.gov registry entry for NCT01247454 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which academic detailing is the first listed.
NCT01247454 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01247454 about?
NCT01247454 is a clinical study titled "Medication Management and Culture of Safety". There will be no significant decrease in the use of low dose acetylsalicylic acid (ASA) therapy for primary prevention across the three intervention arms from baseline to completion of the project. There will be no significant differences in the percentage of patients with diabetes mellitus greater...
What is the current status of trial NCT01247454?
This trial is currently completed. It is a NA study. The enrollment target is 7,000 participants. The study started on 2009-07. Estimated completion is 2010-09.
What interventions are being tested in trial NCT01247454?
The interventions under investigation include: academic detailing (BEHAVIORAL), Electronic Health Record (EHR) prompt (BEHAVIORAL), EHR prompt and patient prompt (BEHAVIORAL).
Who is sponsoring clinical trial NCT01247454?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.